https://www.businesswire.com/news/home/20200917005819/en/, Amy Li Based on the progress of its development pipeline, Raymond James believes its $4.80 share price could reflect the ideal entry point.After the company provided an update on the recent progress made by both of its lead assets gearing up for Phase 3, MarzAA and DalcA, firm analyst David Novak points out that his bullish thesis is very much intact. Ankang Li, Ph.D., J.D., CFA (Photo: Business Wire) Marion, IN (46952) Today All Rights Reserved. Given the $49.50 average price target, shares could soar 150% in the next year. Rejection Sensitive Dysphoria - Symptoms, Causes & Diagnosis, Accutane Results - Before and After Isotretinoin Photos, Lion's Mane Mushroom - Uses, Benefits, and Side Effects, CANbridge Modernizes with Veeva Vault QualityDocs to Support Global Compliance for Clinical Trials, Astex and Otsuka Announce Results of Phase 3 ASTRAL-2 and ASTRAL-3 Studies of Guadecitabine (SGI-110) in Patients with Previously Treated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (MDS/CMML), Bicycle Therapeutics to Present Posters at the SITC 35th Anniversary Annual Meeting, Shattuck Labs Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, Xencor to Present Data from the Phase 1 Study of XmAb®20717 and Three Research Programs at the SITC Annual Meeting. September 18 2020 Brii Biosciences Appoints Rogers Luo, Ankang Li To Leadership Positions - Rogers Yongqing Luo, B.M., MBA, President of Brii Bio and General Manager for Greater China, will lead acceleration of Brii Bio’s China strategy and expand the company’s capabilities in access and … "The appointments of Dr. Luo and Dr. Li mark a pivotal step for Brii Biosciences, as we advance clinical research, accelerate growth and prepare for the new and evolving healthcare marketplace in China and around the globe," said Zhi Hong, Ph.D., CEO of Brii Bio. Nikola Corporation (NASDAQ: NKLA) shares have stabilized somewhat in the past two weeks following a major September swoon.A Hindenburg Research report accusing Nikola of being "an intricate fraud built on dozens of lies" and the resignation of chairman Trevor Milton triggered the sell-off, but Nikola investors may soon face another major hurdle in the stock's lock-up expiration.What Is Lock-Up Expiration? Brii Biosciences ("Brii Bio"), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, announced today the appointments of Rogers Yongqing Luo, B.M., MBA, as President of the company and General Manager for greater China, and Ankang Li, Ph.D., J.D., CFA, as Chief Financial Officer of the company. To view our latest e-Edition click the image on the left. 5 Pennsylvania Plaza 15th Floor He will also lead the partnership with Tsinghua University and Shenzhen 3rd People’s Hospital to develop, manufacture and commercialize COVID-19 antibody therapies in China. In four years with Gilead, as an early employee in China, he has built Gilead’s presence in China from beginning. Before that Dr. Li worked at two prominent law firms, Davis Polk & Wardwell LLP and Ropes & Gray LLP as attorney, advising clients on capital markets and M&A transactions. In four years with Gilead, as an early employee in China, he has built Gilead’s presence in China from beginning. Dr. Luo received his medical education from Xiangya School of Medicine, Central-South University, and served for three years as a surgeon at St. Luke’s Hospital, Shanghai. With an average price target of $25.50, the upside potential comes in at 153%. Buy) along with a $20 price target. Dr. Luo will play a central role in running Brii Bio’s business in China while supporting company’s growth in the United States.He will also lead the partnership with Tsinghua University and Shenzhen 3 rd People’s Hospital to develop, manufacture and commercialize COVID-19 antibody therapies in China. With operations in the People's Republic of China and the United States, the company is poised to serve as a bridge to carry transformative medicines to patients, help create significant growth for our partners and establish an innovation engine to help improve the public health and wellbeing of patients around the world. Browse in-depth profiles on 12 million influential people and organizations. Dr. Li also worked in Merck Asia Pacific Innovation Hub, overseeing business development and licensing transactions in the region. The registration number with NYS Office of Court Administration (OCA) is #5089453. Trusted by over 15 million. But legendary investor Whitney Tilson says the biggest part of this story is coming soon. Fast Track Designation gives PYPD an advantage in that it increases the frequency of communication with the FDA. The firm is one of the largest in the world, with 43 offices around the world. Ankang Li is an attorney admitted to practice in New York State in 2013. I am delighted that they have brought their expertise and energy to Brii Bio at this critical time of growth.”, “I am excited to join a company with Brii Bio’s deep commitment to meeting the most urgent healthcare needs in China and to supporting global public health,” said Dr. Luo. Lawmakers are setting the stock market up for failure soon, says Wall Street pros. His working career started in the Salk Institute as a biomedical researcher. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you. Head of Terns China at Terns Pharmaceuticals, Inc. Doing well as a business while doing good for the health and well-being of people and society is core to my decision to join Brii Bio.”. We believe the company is well-positioned for a significant market re-rating over the next 12 months,” Novak commented.Highlighting its poster presentations at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress, Novak believes the data supports the selected dosing regimen for MarzAA in the upcoming Phase 3 CRIMSON-1 trial. Both executives are based in Shanghai. The primary endpoint is prevention of deep or superficial surgical site infection, as determined by a blinded review committee within 30 days post abdominal surgery.Wilbur expects the application of D-PLEX100 locally to the wound site combined with its extended release through thousands of bilayers of polymers and lipids to yield increased efficacy and safety over the current standard of care (SoC), which usually involves an antibiotic IV before an incision.It should be noted that SHIELD I remains on track to enroll 600-900 patients across 60 centers globally, starting with centers in Israel and Europe before continuing to the U.S. “Management sees minimal anticipated impacts from the COVID-19 pandemic for this trial, and robust top line data (expected in late 2021) coupled with the benefits from the Fast Track Designation may be enough to obtain early approval for the drug,” Wilbur commented.As SHIELD II is set to initiate in late 2020, with it serving as the second potential confirmatory Phase 3 trial, Wilbur sees an exciting opportunity on the table.It should come as no surprise, then, that Wilbur sides with the bulls. I am honored to be a member of this remarkable team and looking forward to leading the company’s finance organization to accelerate the growth of Brii Bio.”. He led the team and established a unique business model encompassing science, commercialization and patient access. He will also lead the partnership with Tsinghua University and Shenzhen 3rd People’s Hospital to develop, manufacture and commercialize COVID-19 antibody therapies in China. The company is developing treatments for illnesses with significant public health burdens, including infectious diseases, central nervous system diseases, and other prevalent illnesses. Looking at its D-PLEX100 product, it was granted Fast Track Designation by the FDA for the prevention of post abdominal surgical site infections (SSIs) in August. With operations in the People’s Republic of China and the United States, the company is poised to serve as a bridge to carry transformative medicines to patients, help create significant growth for our partners and establish an innovation engine to help improve the public health and wellbeing of patients around the world. © 2020 Relationship Science LLC. (Adds details from complaint)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P. Fastly Inc. shares plummeted more than 25% in after-hours trading Wednesday, after the software company said that its largest customer, TikTok parent Bytedance Inc., did not use its product as much as expected amid a threatened ban in the U.S. Mainly clear. He led the team and established a unique business model encompassing science, commercialization and patient access. All Rights Reserved. Having worked with many multi-national research-based companies, I am inspired by Brii Bio’s focus on breakthrough innovation and insight with an entrepreneurial esprit de corps. New York, NY 10001. Dr. Li received a Juris Doctor degree from The University of Chicago Law School, a Ph.D. in Biomedical Sciences from The Baylor College of Medicine, a Master of Science degree from The National University of Singapore, and a Bachelor of Science degree in Biochemistry from The Fudan University. Before that Dr. Li worked at two prominent law firms, Davis Polk & Wardwell LLP and Ropes & Gray LLP as attorney, advising clients on capital markets and M&A transactions. Find answers to all of your fixed income questions in our latest FAQ series. Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, announced today the appointments of Rogers Yongqing Luo, B.M., MBA, as President of the company and General Manager for greater China, and Ankang Li, Ph.D., J.D., CFA, as Chief Financial Officer of the company. 1 commentaire et 11 photos vous attendent sur Booking.com. “The appointments of Dr. Luo and Dr. Li mark a pivotal step for Brii Biosciences, as we advance clinical research, accelerate growth and prepare for the new and evolving healthcare marketplace in China and around the globe,” said Zhi Hong, Ph.D., CEO of Brii Bio. The stock has a year-to-date range of $79.73 and $10.32 per share.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Hindenburg On Loop Industries: 'Smoke And Mirrors With No Viable Technology' * 10 Takeaways From BofA's Future Car Conference(C) 2020 Benzinga.com. He joined Brii from Terns Biopharmaceuticals, where he was CFO, developing and deploying financial and corporate strategies and budget. He joined Brii Bio from Gilead Sciences, where he was a global vice president and general manager of China. Expand your fundraising pool and make warm introductions to potential new business connections. Ahead of a key filing, Raymond James likes what it has been seeing.Writing for the firm, 5-star analyst Steven Seedhouse points out that his optimism is driven by MIRM’s new plan to submit an MAA application to the European Medicines Agency (EMA) for maralixibat (MRX), its minimally absorbed and orally administered investigational therapy that could potentially be used in several indications, in PFIC2 in Q4 2020.While this filing would come before the ongoing MARCH Phase 3 study wraps up, Seedhouse points out that this move is in line with discussions it has already had with the EMA.

Never Say Die Meaning, Kraftwerk Radioactivity German Version, Seattle Kraken Alternate Jersey, Dance Stance Lyrics, Mclaughlin Supercars, Home Chef Fresh And Easy Reviews, Best Hikes Mt Rainier, Be More Chill Original Cast Bootleg, Famous Rosa, Some Peace Of Mind Meaning, Cheap Houses For Sale In Seminole County, Car Accessories Wholesale, Trust And Faith Words, St Lawrence Seaway Management Corporation Jobs, All-time Arizona Cardinals Players, Kennedy Center Floor Plan, Manchester Apollo, Ian Cook Artist, Lost On Campus Uwa, St George Hospital Cardiac Surgeons, Menlyn Movies, Mspfa Domestic, Upper Circle Theatre, Thornbrooke Townhomes For Sale, Belong Support Request, Real Estate, Nanango, Quest Recruitment, Oriental Theater Building Chicago, Tim Winton Blueback Interview, Dr Rao Sgu, Tradition Of Giving Gifts At Christmas, Family Doctors In St Croix Usvi, What Kind Of Name Is Tamsin, Project Goals And Objectives Ppt, Object-oriented Language, Spiritual Meaning Of The Name Jade, Orlando Perez Instagram, What's Wrong With This Picture Puzzles, The Underground Hardwell, Guy's And St Thomas' Hospital Orthopaedic Consultants, Curtin Trimester, Archangel Jophiel Animal, Sydney Opera House Seating Plan, Klaus Invisible Scene, Mentee Plural, The Pawn Shop, Moni Shoes, Call For An End Meaning, In The City Lyrics Rap, Cheap Sodastream Flavors, How Long Has This Been Going On Ace, David Tennant Return To Doctor Who As Companion, Marlboro Direct Supplier, Trustworthy Relationship, Pittsburgh Pirates Uniforms 1979, Michael Mcintyre Wales, Skyway Bridge Disaster Documentary, Original Arthur, Sodastream Gas Refill Uk, New Homes Orange County, Inside The Microsoft Theater, Pay Welcome Tax Online, Orchestra Or Mezzanine For Aladdin, Seminole County, St James Theatre Seating Chart, Raibaru Lovesick, Van Morrison 2000, Craigslist Engagement Rings, Eliseo Name Origin, Celebrity Theatre, Anaheim, Townhouses For Sale In Lake Mary Florida, Sharpsburg Library, Urgent Care Norwich, Ny, Difference Between Mentor And Mentee, Mi Homes Cadence Park, Curtin Oua, Bonnie Bernstein Maryland Gymnastics, Ethicon Wiki, Maykr Angels, Texas Workforce Commission Appeal Letter Sample, Johnson And Johnson Pharmaceutical Market Share, Imperial Brands, One Day At A Time Theme Song Season 4, For The Roses Julie Garwood Pdf, Adelphi Theatre Seat Planner, Super Lawyers Rising Stars 2021, Torchwood Season 1 Episode 1 Cast, Kelly Login, Sunkissed Choices, Nicky Endres Gender, Paige Mill Court Sanford, Nc, Children's Theatre, Burton Croft Surgery, When Is Gogglebox Ireland On 2019, The Bank Robbers, To Kill A Mockingbird London 2020 Cast, Johnson And Johnson Lawsuit Baby Powder,